Canaccord Genuity revised its price target for Cybin Inc. (NYSE:CYBN) shares, reducing it to $73.00 from the previous $86.00, ...

Canaccord Genuity adjusted its stance on Evolution Mining Ltd. (EVN:AU) (OTC: CAHPF), downgrading the company's stock rating ...

Aurora Innovation, Inc. (NASDAQ: AUR) today announced David Maday, Chief Financial Officer, will participate in a virtual ...

The surprise retirement of Dunelm's boss shouldn't put off investors from the homeware retailer's strong growth prospects, ...

In a report released yesterday, Alexander Bedwany from Canaccord Genuity reiterated a Buy rating on Kodal Minerals (KOD – Research Report), ...

Canaccord Genuity has downgraded Pliant (PLRX) to hold following news that the company has paused a clinical trial for its ...

Vertex Pharmaceuticals (VRTX) stock gets an upgrade from Canaccord Genuity after its Q4 2024 results on Tuesday, Read more here.

Pliant Therapeutics (NASDAQ:PLRX – Get Free Report)‘s stock had its “hold” rating restated by research analysts at Canaccord Genuity Group in a note issued to investors on Monday, MarketBeat reports.

Canaccord Genuity analyst Alexander Bedwany reiterated a Sell rating on South32 Ltd. (S32 – Research Report) yesterday and set a price target ...

Uncertainty around North American trade has hindered capital-markets activity and stalled investments in Canada, according to ...

Canopy Growth (TSE:WEED – Get Free Report) had its target price decreased by analysts at Canaccord Genuity Group from C$2.50 to C$1.50 in a research report issued to clients and investors on ...

Analysts at Canaccord Genuity slightly raised their target price on Celtic from 202.0p to 208.0p on Tuesday, stating the firm ...